Increase of carbapenem-resistant Acinetobacter baumannii infection in acute care hospitals in Taiwan: association with hospital antimicrobial usage
about
Infection Control Programs and Antibiotic Control Programs to Limit Transmission of Multi-Drug Resistant Acinetobacter baumannii Infections: Evolution of Old Problems and New Challenges for InstitutesAntimicrobial resistance in Acinetobacter baumannii: From bench to bedsideSurveillance and correlation of antimicrobial usage and resistance of Pseudomonas aeruginosa: a hospital population-based studyBiology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment OptionsEmergence of extensively drug-resistant Acinetobacter baumannii complex over 10 years: nationwide data from the Taiwan Surveillance of Antimicrobial Resistance (TSAR) program.Antimicrobial susceptibilities of Proteus mirabilis: a longitudinal nationwide study from the Taiwan surveillance of antimicrobial resistance (TSAR) programRisk factors for excessively prolonged meropenem use in the intensive care setting: a case-contol study.Comparative Phosphoproteomics Reveals the Role of AmpC β-lactamase Phosphorylation in the Clinical Imipenem-resistant Strain Acinetobacter baumannii SK17.Controlling endemic multidrug-resistant Acinetobacter baumannii in Intensive Care Units using antimicrobial stewardship and infection controlAnalysis of tigecycline resistance development in clinical Acinetobacter baumannii isolates through a combined genomic and transcriptomic approach.Molecular epidemiology of integron-associated antimicrobial gene cassettes in the clinical isolates of Acinetobacter baumannii from northern TaiwanThe Antimicrobial Susceptibility of Klebsiella pneumoniae from Community Settings in Taiwan, a Trend Analysis.Improvement of in vivo antimicrobial activity of HBcARD peptides by D-arginine replacement.Bacteraemia in Intensive Care Unit: Clinical, Bacteriological, and Prognostic Prospective Study.Correlation between antibiotic consumption and resistance of bloodstream bacteria in a University Hospital in North Eastern Italy, 2008-2014.Effects of Group 1 versus Group 2 carbapenems on the susceptibility of Acinetobacter baumannii to carbapenems: a before and after intervention study of carbapenem-use stewardship.Trends and correlation of antibacterial usage and bacterial resistance: time series analysis for antibacterial stewardship in a Chinese teaching hospital (2009-2013).In vitro activity of rifampicin alone and in combination with imipenem against multidrug-resistant Acinetobacter baumannii harboring the blaOXA-72 resistance gene.Carbapenem-resistant Gram-negative bacteria: how to prioritize infection prevention and control interventions in resource-limited settings?Correlations of antibiotic use and carbapenem resistance in enterobacteriaceae.Surveillance and correlation of antibiotic consumption and resistance of Acinetobacter baumannii complex in a tertiary care hospital in northeast China, 2003-2011.Clinical and economic impact of antibiotic resistance in developing countries: A systematic review and meta-analysis.Management of carbapenem-resistant Acinetobacter baumannii epidemic in an intensive care unit using multifaceted intervention strategy.
P2860
Q26799202-035B3D95-12E9-4AFC-9E66-14B57229B5C3Q27024893-D7E39346-D97D-4851-8922-D17B4F8FA88CQ28535024-F8ED134B-4D34-492D-AA89-577AC29BBDACQ30235064-AC2B04CE-4C48-4377-AB4E-1AE0C1EB690DQ30559669-5D13BE88-9791-4C97-B767-EB4760A45A9AQ34174397-19A44BAC-B533-492A-A5A5-B95D43AC5EE8Q36274473-62BC389F-EE91-4099-A09F-5E14038D2753Q36604103-D218850C-44DA-4E00-8430-733C881D8B77Q36638145-18900F1B-1B42-45E9-8D2C-DE9F230DAEAFQ36949625-F6A6B41E-747C-48CB-9483-AB49001FC250Q36973051-62BE6520-C98D-4E41-BEB2-14607E6A3329Q37400286-606541D2-8A0C-45A3-8442-FDE50E5A8C90Q38860727-7642A223-2578-45BE-8C75-4537BD065257Q40242806-AAA5717C-A419-46C3-A3C2-E48C14F0621DQ40305798-2F45B784-6456-489F-89F9-2E9C3643D8F9Q40445690-22F29A70-F70F-4A65-AF5F-4C30681233AFQ41610406-C40DB02E-CF41-422C-94B8-29EE9C6FDC76Q42232084-819F7206-188B-45FB-B644-A36ED12A2E9BQ42275030-511EFE75-1AA5-4658-B794-475686F97D56Q42930238-60E711CD-FD6E-4B8E-931D-48C8F049C524Q43095257-95ECBD33-403C-4477-9DE5-7D39D0E56FC0Q48364629-AAAE7B0B-AC22-44F8-B668-7FA5A770DC32Q48591028-BF12F412-CECE-4FC6-A60F-E711291B32A4
P2860
Increase of carbapenem-resistant Acinetobacter baumannii infection in acute care hospitals in Taiwan: association with hospital antimicrobial usage
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Increase of carbapenem-resista ...... h hospital antimicrobial usage
@ast
Increase of carbapenem-resista ...... h hospital antimicrobial usage
@en
Increase of carbapenem-resista ...... h hospital antimicrobial usage
@en-gb
Increase of carbapenem-resista ...... h hospital antimicrobial usage
@nl
type
label
Increase of carbapenem-resista ...... h hospital antimicrobial usage
@ast
Increase of carbapenem-resista ...... h hospital antimicrobial usage
@en
Increase of carbapenem-resista ...... h hospital antimicrobial usage
@en-gb
Increase of carbapenem-resista ...... h hospital antimicrobial usage
@nl
altLabel
Increase of Carbapenem-Resista ...... h Hospital Antimicrobial Usage
@en
prefLabel
Increase of carbapenem-resista ...... h hospital antimicrobial usage
@ast
Increase of carbapenem-resista ...... h hospital antimicrobial usage
@en
Increase of carbapenem-resista ...... h hospital antimicrobial usage
@en-gb
Increase of carbapenem-resista ...... h hospital antimicrobial usage
@nl
P2093
P2860
P921
P3181
P1433
P1476
Increase of carbapenem-resista ...... h hospital antimicrobial usage
@en
P2093
Chao A Hsiung
Cheng-Liang Chi
Chiu-Hsia Su
Feng-Yee Chang
Hui-Tzu Yu
Li-Jung Chien
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0037788
P407
P577
2012-01-01T00:00:00Z